IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ligand Pharmaceuticals I

Q1 2015 vs Q2 2015

Comparing institutional holders between quarters

Quarters

Q2 2015Q1 2015Q4 2014Q3 2014Q2 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Advent Capital Management
DECREASED
Shares4,330,000 from 17,107,000
Change-12,777,000 (-75%)
Value$6.3K (-$14.5K)
Filed 2015-07-24
Status
Advent Capital Management
DECREASED4,330,00017,107,000-12,777,000-75%$20.7K$6.3K-$14.5K2015-07-24
Showing 1 of 1 institutions